Biologics Formulation Development - Abzena

Biologics Formulation Development

Over 20 years of biologic formulation development expertise, data and knowledge tailored for your product.

Download Info Sheet

Tailored formulation development.

Biologics are known for their intricate molecular structures and precise therapeutic actions. They demand a sophisticated formulation process tailored to their unique characteristics and stability needs. At Abzena, our experienced scientific team specializes in developing complex biological compounds, harnessing the latest technologies to assist in optimizing each formulation for solubility, delivery, safety, and sustained stability.

Contact Us

Customized for your molecule and development phase, Abzena align your drug to your preferred target product profile (TPP) with a comprehensive range of formulation development packages including stable liquid and lyophilized formulations.

We select your best lead candidate through screening of optimal buffer conditions and formulation options to inform successful drug substance manufacturing conditions and drug product forms that support long-term stability.

Our team is experienced in developing formulations for small and large therapeutic molecules such as peptides, proteins, monoclonal antibodies and antibody-drug conjugates (ADCs).

Navigate the complex concept-to-market pathway with the full support Abzena.

Our customer-centric approach across a broad range of formulation development services enables us to support a biopharmaceutical product throughout its entire lifecycle – from initial preformulating studies and generation of a formulation to support toxicology and first-in-human (FIH) clinical trials through to clinical in-use studies, formulation optimization, robustness, and device interaction studies.

Fully Integrated Formulation Development Support

Our unique approach enables customers to utilize a single organization for all their formulation and manufacturing requirements, which streamlines and de-risks the process and allows any experience and learnings to be shared across teams. This first-hand knowledge of the product can then be applied to rapidly solve any complex problems which may arise downstream.

Contact Us

Our Formulation Development Capabilities

Our state-of-the-art laboratories are equipped with the latest analytical equipment and methods to evaluate the integrity of your drug under an array of conditions to inform optimal formulation constituents and forms.

Our capabilities include:

  • UHPLC systems
  • Biophysical stability assessment platforms and particle size assessment equipment such as Prometheus, UNcle and ZetaSizer Ultra
  • Mass spectrometry instruments (TOF MS, QTOF MS)
  • Microfluidic platform (LabChip)
Contact Us

Comprehensive Support Across Multiple Modalities

Bioconjugate & ADC Formulation Development - Abzena

Having delivered over 1400+ programs, we excel in developing formulations for a diverse range of therapeutic modalities offering fully integrated formulation development support across:

→ Monoclonal Antibodies (mAbs)
→ Antibody-Drug Conjugates (ADCs)
→ Antibody-Oligonucleotide Conjugates (AOCs)
→ Radioconjugates (RACs/RDCs)
→ Bispecific Antibodies (bsAbs)
→ Fusion Proteins
→ Cytokines
→ Recombinant & Conjugate Vaccines
→ Nanoparticles
→ Biosimilars

Contact Us

Related Content

Formulating a Biologic: Frequently Asked Questions

Learn More

Abzena Announces Expansion of Integrated Biologics Offering with the Addition of Preformulation and Formulation Capability

Learn More

Process Development & Optimization

Our process development, optimization and manufacturing teams collaborate together to develop quality, commercially viable processes ensuring seamless scale up through to commercial launch.

Learn More

Cell Line Development

Leveraging our experience in accelerating biological product development, we generate cell lines with high productivity and the right product quality.

Learn More

Let’s move medicine forward.

We understand the important role that formulation development plays in ensuring both clinical and commercial success for your program. From early discovery through commercial, our experienced scientists can ensure that your new medicine reaches patients in need.

Contact Us